First Horizon Advisors Inc. Purchases New Holdings in Tempus AI, Inc. (NASDAQ:TEM)

First Horizon Advisors Inc. acquired a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 533 shares of the company’s stock, valued at approximately $30,000.

Other hedge funds also recently added to or reduced their stakes in the company. EFG Asset Management North America Corp. purchased a new stake in shares of Tempus AI in the second quarter valued at about $1,333,000. ARK Investment Management LLC purchased a new stake in Tempus AI in the 2nd quarter valued at approximately $18,294,000. Northwestern University acquired a new position in Tempus AI during the 2nd quarter worth approximately $491,000. Alphabet Inc. acquired a new position in Tempus AI during the 2nd quarter worth approximately $54,289,000. Finally, Pier Capital LLC purchased a new position in shares of Tempus AI during the 2nd quarter worth approximately $2,301,000.

Tempus AI Stock Performance

NASDAQ:TEM opened at $63.89 on Tuesday. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The company’s 50-day simple moving average is $52.12. Tempus AI, Inc. has a twelve month low of $22.89 and a twelve month high of $79.49.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the company. Bank of America downgraded Tempus AI from a “buy” rating to a “neutral” rating and lifted their price target for the company from $45.00 to $60.00 in a research note on Wednesday, October 2nd. Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and upped their price target for the stock from $45.00 to $65.00 in a research note on Monday, November 11th. Needham & Company LLC reiterated a “buy” rating and issued a $47.00 price target on shares of Tempus AI in a report on Wednesday, August 7th. Piper Sandler reissued a “neutral” rating and set a $70.00 price objective (up previously from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Finally, JPMorgan Chase & Co. increased their target price on shares of Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $54.22.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.